# Bluesight

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bluesight

- Industry: Healthcare IT
- Headquarters: Alexandria, US
- Website: www.bluesight.com
- Total disclosed funding: $38M
- Latest round: Series C (Jun 20, 2016)
- Investors on record: 10

## About

Based in the US, Bluesight, Inc. operates as a technology company that delivers innovative solutions aimed at optimizing hospital and pharmacy operations through automation and integrated data management.Founded in 2011 and headquartered in Alexandria, US, Bluesight, Inc. specializes in enhancing healthcare operations. The company was co-founded by Kevin MacDonald and Tim Kress-Spatz. In July 2023, Bluesight raised USD 15.00 mn in a Series C funding round led by Baxter Ventures, marking its sixth funding deal. This investment has allowed Bluesight to focus on expanding its inventory management and spend optimization offerings.Bluesight provides a suite of solutions tailored for hospital and pharmacy operations, including RFID Medication Management for inventory automation, KitCheck for drug diversion surveillance, ControlCheck for optimizing retail purchasing, and 340B Compliance solutions for effective auditing. Their services also encompass Drug Shortage Management with predictive analytics and Patient Privacy Monitoring to safeguard personal information. Their clientele is primarily healthcare institutions across the US, benefiting from streamlined operations and actionable insights that address the challenges in diverse healthcare environments.Bluesight generates revenue primarily through an annual subscription model for its software solutions. Key products such as CostCheck and PrivacyPro are included in these subscription packages, focusing on drug spending efficiency and patient privacy enhancement. The company engages in B2B transactions with hospitals and pharmacies, often under multi-year contracts for ongoing support. Their pricing is structured to accommodate various client needs, offering bundled service options for cost savings.Following the recent funding round in July 2023, Bluesight plans to enhance its inventory management and spend optimization capabilities. The company is set to introduce new products aimed at improving hospital efficiency and anticipates expanding its reach into additional regional markets in the US. The investment will support these initiatives, enabling further development of their product offerings and enhancing their market presence.

## Funding rounds

- Series C, Jun 20, 2016, $15M — Easton Capital Investment Group, New Leaf Venture Partners, Kaiser Permanente Ventures, Baxter Ventures, LionBird, Sands Capital Alternatives, Black Granite Capital, Circuit Health, Rex Health Ventures
- Series B, Jan 12, 2015, $12M — Easton Capital Investment Group, New Leaf Venture Partners, Kaiser Permanente Ventures, LionBird, Sands Capital Alternatives, Rex Health Ventures
- Series A, Jul 16, 2013, $10M — Easton Capital Investment Group, New Leaf Venture Partners, LionBird, Sands Capital Alternatives
- Seed, Oct 25, 2012, $0.1M — Rock Health

## Investors

- Rock Health (https://capitalatlas.ai/funds/rock-health) — Seed
- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series A, Series B, Series C
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series A, Series B, Series C
- LionBird (https://capitalatlas.ai/funds/lionbird) — Series A, Series B, Series C
- Sands Capital Alternatives (https://capitalatlas.ai/funds/sands-capital-alternatives) — Series A, Series B, Series C
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series B, Series C
- Rex Health Ventures (https://capitalatlas.ai/funds/rex-health-ventures) — Series B, Series C
- Baxter Ventures (https://capitalatlas.ai/funds/baxter-ventures) — Series C
- Black Granite Capital (https://capitalatlas.ai/funds/black-granite-capital) — Series C
- Circuit Health (https://capitalatlas.ai/funds/circuit-health) — Series C